We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | 66,018 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/6/2023 09:54 | Personally I am more impressed with the wholly independent CEO at SBTX . I give a credibility score of 11/10, I am so impressed | only fools and gerbils | |
13/6/2023 09:51 | The main thing is that the CEO has maintained full market credibility, according to latest reports . Good sign Although the sources of reports are maybe an issue | putinaire | |
13/6/2023 09:43 | Nearly a decade now and between opti and the spin outs , the ceo has done a good job imo Nice car anyway | b2 unabomber | |
13/6/2023 09:40 | Sorry. Wrong thread | b2 unabomber | |
13/6/2023 09:40 | Hmmm not sure it’s ffs All looking highly credible to me | b2 unabomber | |
12/6/2023 23:19 | Tom I don’t suppose you wasted your time asking if they were buying ? | vlad the impaler | |
12/6/2023 21:13 | Nobody is that thick Just sayin T. Abyss | thanatos abyss | |
12/6/2023 18:13 | We need to keep an eye out here for one more play But no sign yet unless their only interest is to sell into next opti rise Certainly no sign of quiet buyers low | putinaire | |
12/6/2023 17:57 | “I shall not label such folks morons. Okay I will. They are morons. I have swapped emails with both Steve O’Hara of Optibiotix and Stuart Ashman of Skins.” Isn’t that market sensitive data? How can they be telling you in an email what they did or did not do? If they were selling , could they tell you? | leopold ii | |
12/6/2023 17:56 | “The bulletin boards are full of ill-informed speculation.” You been calling buy since 119p you think knut Did they tell you what holdings are since last RNS? In fact, did they ever say they ‘are selling/dumping since holding 42%? | leopold ii | |
12/6/2023 17:55 | O’Hara – NO we are NOT dumping Skinbiotherapeutics shares I am told by at least one reader that a 1 million shares sale in Skinbiotherapeutics (SBTX) MUST be Optibiotix (OPTI). The bulletin boards are full of ill-informed speculation. I am in a good mood today because West Ham are Massive so I shall not label such folks morons. Okay I will. They are morons. I have swapped emails with both Steve O’Hara of Optibiotix and Stuart Ashman of Skins. | leopold ii | |
12/6/2023 17:00 | Ffs I forget the epic here . Is it OPTI or SFO? | freddie krugger | |
09/6/2023 11:55 | Wtf you doing g here umpy you should be drowning your sorrows in the piggery | 2pigshit | |
09/6/2023 11:51 | If I was the ceo I’d personally not want a Plc left here after I retired. They might identify all my genius methods and come begging for autographs and advice I’d sink her hard so the main holder can buy it out for 20 pence , and shut the doors But you know, always a play worth watching for in the interim | thanatos abyss | |
09/6/2023 11:49 | Wish i had sold at £1 30 BLOODY big mistake | humphries1 | |
09/6/2023 11:47 | Morning all Fkn bargain All the gurus saw 300p when 130p Now we can buy it for near 6p and make billions | gerbil control | |
08/6/2023 16:54 | This is trading like Syme did before it got suspended . I hope just coincidence | thanatos abyss | |
08/6/2023 11:21 | There was a master called Mel He made Drew look like a smell He took off Drew’s nappy And slapped him all happy Now Drew is on the last knell | institutional investments |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions